Leonard Braden Michael
SEC CIK 1373603 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| OM | Outset Medical, Inc. | 10% | 2.52M | — | — | 2 | 2026-05-08 | 2026-05-15 |
| ACRS | Aclaris Therapeutics, Inc. | 10% | 13.95M | $5.59M | $1.36M | 8 | 2024-06-11 | 2026-04-23 |
| ASTC | ASTROTECH Corp | 10% | 0 | $809.8K | $1.62M | 9 | 2022-08-23 | 2025-10-03 |
| ANTX | AN2 Therapeutics, Inc. | 10% | 3.22M | $1.56M | $3.09M | 3 | 2024-08-14 | 2025-05-28 |
| OKUR | OnKure Therapeutics, Inc. | Former 10% owner of RPHM | 102.1K | $1.72M | — | 7 | 2024-05-14 | 2024-10-07 |
| TECX | Tectonic Therapeutic, Inc. | Former 10% owner of AVROBIO | 33.3K | $972.8K | — | 3 | 2024-05-13 | 2024-06-20 |
| ELVN | Enliven Therapeutics, Inc. | 10% | 1.77M | $964.8K | $10.36M | 9 | 2022-04-21 | 2023-01-04 |
| RVP | RETRACTABLE TECHNOLOGIES INC | 10% | 688.6K | $3.23M | $5.31M | 7 | 2022-04-28 | 2022-12-29 |
| IRON | Disc Medicine, Inc. | 10% | 247.5K | $1.34M | $47.0K | 3 | 2022-04-11 | 2022-10-26 |
Most active insiders at OM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Trigg Leslie | COB, CEO, Dir | — | $122.1K |
| 2 | Gaeta Renee | CFO | — | $107.2K |
| 3 | Brottem John L. | GC | — | $87.2K |
| 4 | Nash Marc | EVP Ops R, D, Service | — | $45.9K |
| 5 | Drexler Karen | Dir | — | $6,765 |
| 6 | Elliott Derick A. | EVP, Commercial | — | — |
| 7 | Prange Karen | Dir | — | — |
| 8 | LANG BRENT D. | Dir | — | — |
| 9 | Leonard Braden Michael | 10% | — | — |
| 10 | HACKETT PATRICK T | Dir | — | — |
Transactions 51
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-05-18 09:53 | 2026-05-15 | OM | Outset Medical, Inc. | Leonard Braden Michael | 10% | X - OptEx | $5.00 | +323.0K | 2.52M | +15% | +$1.61M |
| MI | 2026-05-12 16:34 | 2026-05-08+ | OM | Outset Medical, Inc. | Leonard Braden Michael | 10% | X - OptEx | $5.00 | +294.5K | 2.20M | +15% | +$1.47M |
| I | 2026-04-27 19:27 | 2026-04-23 | ACRS | Aclaris Therapeutics, Inc. | Leonard Braden Michael | 10% | S - Sale | $4.53 | -300.0K | 13.95M | -2% | -$1.36M |
| 2025-10-07 | 2025-10-03 | ASTC | ASTROTECH Corp | Leonard Braden Michael | 10% | S - Sale | $5.83 | -9,166 | 0 | -100% | -$53.4K | |
| I | 2025-10-07 | 2025-10-03 | ASTC | ASTROTECH Corp | Leonard Braden Michael | 10% | S - Sale | $7.13 | -220.4K | 0 | -100% | -$1.57M |
| I | 2025-06-16 | 2025-05-28 | ANTX | AN2 Therapeutics, Inc. | Leonard Braden Michael | 10% | S - Sale | $1.09 | -200.0K | 3.02M | -6% | -$218.0K |
| MI | 2025-05-30 | 2025-05-28+ | ANTX | AN2 Therapeutics, Inc. | Leonard Braden Michael | 10% | S - Sale | $1.13 | -2.53M | 3.22M | -44% | -$2.87M |
| 2024-10-09 | 2024-10-07 | OKUR | OnKure Therapeutics, Inc. | Leonard Braden Michael | Former 10% owner of RPHM | J - Other | — | +102.1K | 102.1K | New | — | |
| I | 2024-10-09 | 2024-10-07 | OKUR | OnKure Therapeutics, Inc. | Leonard Braden Michael | Former 10% owner of RPHM | J - Other | — | +345.7K | 345.7K | New | — |
| MI | 2024-09-26 | 2024-09-24+ | OKUR | OnKure Therapeutics, Inc. | Leonard Braden Michael | 10% | P - Purchase | $1.47 | +98.3K | 3.46M | +3% | +$144.9K |
| MI | 2024-09-19 | 2024-09-17+ | OKUR | OnKure Therapeutics, Inc. | Leonard Braden Michael | 10% | P - Purchase | $1.36 | +56.1K | 3.36M | +2% | +$76.3K |
| MI | 2024-09-16 | 2024-09-12+ | OKUR | OnKure Therapeutics, Inc. | Leonard Braden Michael | 10% | P - Purchase | $1.35 | +358.9K | 2.98M | +14% | +$483.8K |
| I | 2024-08-14 | 2024-08-14 | ANTX | AN2 Therapeutics, Inc. | Leonard Braden Michael | 10% | P - Purchase | $1.04 | +1.50M | 5.75M | +35% | +$1.56M |
| MI | 2024-08-14 | 2024-08-13+ | OKUR | OnKure Therapeutics, Inc. | Leonard Braden Michael | 10% | P - Purchase | $1.40 | +271.8K | 2.94M | +10% | +$379.8K |
| MI | 2024-08-05 | 2024-08-02+ | ACRS | Aclaris Therapeutics, Inc. | Leonard Braden Michael | 10% | P - Purchase | $1.26 | +373.6K | 14.25M | +3% | +$471.6K |
| MI | 2024-07-31 | 2024-07-30+ | ACRS | Aclaris Therapeutics, Inc. | Leonard Braden Michael | 10% | P - Purchase | $1.31 | +273.7K | 13.78M | +2% | +$358.8K |
| MI | 2024-07-22 | 2024-07-18+ | ACRS | Aclaris Therapeutics, Inc. | Leonard Braden Michael | 10% | P - Purchase | $1.30 | +154.7K | 13.58M | +1% | +$201.7K |
| MI | 2024-07-05 | 2024-07-02+ | ACRS | Aclaris Therapeutics, Inc. | Leonard Braden Michael | 10% | P - Purchase | $1.15 | +352.4K | 13.32M | +3% | +$405.8K |
| MI | 2024-07-01 | 2024-06-27+ | ACRS | Aclaris Therapeutics, Inc. | Leonard Braden Michael | 10% | P - Purchase | $1.13 | +1.54M | 12.59M | +14% | +$1.74M |
| 2024-06-25 | 2024-06-20 | TECX | Tectonic Therapeutic, Inc. | Leonard Braden Michael | Former 10% owner of AVROBIO | J - Other | — | +33.3K | 33.3K | New | — | |
| I | 2024-06-25 | 2024-06-20 | TECX | Tectonic Therapeutic, Inc. | Leonard Braden Michael | Former 10% owner of AVROBIO | J - Other | — | +400.4K | 400.4K | New | — |
| MI | 2024-06-18 | 2024-06-14+ | ACRS | Aclaris Therapeutics, Inc. | Leonard Braden Michael | 10% | P - Purchase | $1.16 | +545.0K | 11.55M | +5% | +$629.6K |
| MI | 2024-06-13 | 2024-06-11+ | ACRS | Aclaris Therapeutics, Inc. | Leonard Braden Michael | 10% | P - Purchase | $1.11 | +1.61M | 11.01M | +17% | +$1.78M |
| MI | 2024-05-16 | 2024-05-14 | OKUR | OnKure Therapeutics, Inc. | Leonard Braden Michael | 10% | P - Purchase | $1.54 | +414.3K | 2.67M | +18% | +$639.6K |
| MI | 2024-05-15 | 2024-05-13+ | TECX | Tectonic Therapeutic, Inc. | Leonard Braden Michael | 10% | P - Purchase | $1.27 | +766.6K | 4.47M | +21% | +$972.8K |
| AI | 2023-01-05 | 2023-01-03 | ELVN | Enliven Therapeutics, Inc. | Leonard Braden Michael | 10% | S - Sale | $4.00 | -1.25M | 1.77M | -41% | -$5.00M |
| I | 2023-01-04 | 2023-01-04 | ELVN | Enliven Therapeutics, Inc. | Leonard Braden Michael | 10% | S - Sale | $4.00 | -1.25M | 1.77M | -41% | -$5.00M |
| 2022-12-30 | 2022-12-30 | ELVN | Enliven Therapeutics, Inc. | Leonard Braden Michael | 10% | S - Sale | $4.04 | -20.0K | 230.0K | -8% | -$80.8K | |
| M | 2022-12-29 | 2022-12-28+ | ELVN | Enliven Therapeutics, Inc. | Leonard Braden Michael | 10% | S - Sale | $4.04 | -20.0K | 269.8K | -7% | -$80.8K |
| I | 2022-12-29 | 2022-12-29 | RVP | RETRACTABLE TECHNOLOGIES INC | Leonard Braden Michael | 10% | S - Sale | $1.60 | -3.00M | 688.6K | -81% | -$4.80M |
| M | 2022-12-27 | 2022-12-22+ | ELVN | Enliven Therapeutics, Inc. | Leonard Braden Michael | 10% | S - Sale | $4.06 | -50.0K | 318.9K | -14% | -$203.0K |
| I | 2022-12-02 | 2022-12-02 | ASTC | ASTROTECH Corp | Leonard Braden Michael | 10% | P - Purchase | $0.34 | +191.0K | 6.61M | +3% | +$64.9K |
| MI | 2022-11-30 | 2022-11-28+ | RVP | RETRACTABLE TECHNOLOGIES INC | Leonard Braden Michael | 10% | S - Sale | $2.00 | -252.4K | 3.92M | -6% | -$505.5K |
| I | 2022-11-25 | 2022-11-23 | ASTC | ASTROTECH Corp | Leonard Braden Michael | 10% | P - Purchase | $0.33 | +75.0K | 6.42M | +1% | +$24.8K |
| MI | 2022-11-18 | 2022-11-16+ | ASTC | ASTROTECH Corp | Leonard Braden Michael | 10% | P - Purchase | $0.3703 | +390.5K | 6.21M | +7% | +$144.6K |
| 2022-10-27 | 2022-10-26 | IRON | Disc Medicine, Inc. | Leonard Braden Michael | 10% | S - Sale | $2.09 | -22.5K | 247.5K | -8% | -$47.0K | |
| MI | 2022-10-18 | 2022-10-14+ | ASTC | ASTROTECH Corp | Leonard Braden Michael | 10% | P - Purchase | $0.3823 | +216.4K | 5.91M | +4% | +$82.7K |
| MI | 2022-09-27 | 2022-09-23+ | ASTC | ASTROTECH Corp | Leonard Braden Michael | 10% | P - Purchase | $0.4372 | +357.9K | 5.74M | +7% | +$156.5K |
| MI | 2022-09-07 | 2022-09-01+ | ASTC | ASTROTECH Corp | Leonard Braden Michael | 10% | P - Purchase | $0.4652 | +252.1K | 5.38M | +5% | +$117.2K |
| MI | 2022-08-25 | 2022-08-23+ | ASTC | ASTROTECH Corp | Leonard Braden Michael | 10% | P - Purchase | $0.457 | +479.3K | 4.96M | +11% | +$219.0K |
| I | 2022-06-21 | 2022-06-16 | ELVN | Enliven Therapeutics, Inc. | Leonard Braden Michael | 10% | P - Purchase | $1.11 | +83.2K | 3.02M | +3% | +$92.4K |
| MI | 2022-06-07 | 2022-06-03+ | ELVN | Enliven Therapeutics, Inc. | Leonard Braden Michael | 10% | P - Purchase | $1.14 | +33.4K | 2.93M | +1% | +$38.2K |
| MI | 2022-05-25 | 2022-05-23+ | RVP | RETRACTABLE TECHNOLOGIES INC | Leonard Braden Michael | 10% | P - Purchase | $3.98 | +63.5K | 3.72M | +2% | +$252.9K |
| MI | 2022-05-19 | 2022-05-17+ | RVP | RETRACTABLE TECHNOLOGIES INC | Leonard Braden Michael | 10% | P - Purchase | $3.82 | +140.1K | 3.60M | +4% | +$534.9K |
| MI | 2022-05-18 | 2022-05-16+ | ELVN | Enliven Therapeutics, Inc. | Leonard Braden Michael | 10% | P - Purchase | $1.23 | +41.1K | 2.90M | +1% | +$50.5K |
| MI | 2022-05-16 | 2022-05-12+ | RVP | RETRACTABLE TECHNOLOGIES INC | Leonard Braden Michael | 10% | P - Purchase | $3.96 | +139.9K | 3.56M | +4% | +$553.7K |
| MI | 2022-05-11 | 2022-05-09+ | RVP | RETRACTABLE TECHNOLOGIES INC | Leonard Braden Michael | 10% | P - Purchase | $3.82 | +73.5K | 3.37M | +2% | +$280.9K |
| MI | 2022-05-02 | 2022-04-28+ | RVP | RETRACTABLE TECHNOLOGIES INC | Leonard Braden Michael | 10% | P - Purchase | $3.73 | +430.0K | 3.08M | +16% | +$1.60M |
| MI | 2022-04-25 | 2022-04-21+ | ELVN | Enliven Therapeutics, Inc. | Leonard Braden Michael | 10% | P - Purchase | $1.40 | +560.0K | 2.85M | +24% | +$783.8K |
| MI | 2022-04-13 | 2022-04-11+ | IRON | Disc Medicine, Inc. | Leonard Braden Michael | 10% | P - Purchase | $1.40 | +900.0K | 4.81M | +23% | +$1.26M |
| 2022-04-13 | 2022-04-12 | IRON | Disc Medicine, Inc. | Leonard Braden Michael | 10% | P - Purchase | $1.37 | +55.0K | 270.0K | +26% | +$75.3K |
Purchase Sale Sale after option exercise All abbreviations